Horizon Therapeutics, a biotech company focused on rare, autoimmune and severe inflammatory diseases, sued Teva Pharmaceuticals on April 5 in Delaware District Court over patent infringement claims.

California. At 64,789, April's job cuts were down significantly from the 90,000 cuts announced in March and slightly down from the 66,995 announced in April of 2023. So far this year, almost ...

Teva’s 2023 Healthy Future Report highlights the Company’s renewed sustainability strategy, which guides Teva in addressing global challenges while also supporting its business, allowing for ...

TEL AVIV, Israel & PARSIPPANY, N.J., April 11, 2024--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced results from a Phase 3 ...

Alvotech (NASDAQ:ALVO) in agreement with Teva Pharmaceuticals (NYSE:TEVA), signed a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryvk in the U.S. market ...

REYKJAVIK, Iceland and PARSIPPANY, N.J., April 16, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE ...

The biosimilar, called Selarsdi, will be marketed in the US by Alvotech (ALVO) partner Teva Pharmaceuticals (NYSE:TEVA) following a settlement with J&J. Teva intends to launch the product on or ...

opens new tab global job cuts include reducing staff in the U.S. and China, the automakers' two biggest markets, across sales, tech, and engineering, five sources briefed on the matter said.

UK universities will be forced to step up course closures and job cuts unless the government addresses a looming structural funding crisis in the sector, according to higher education leaders.

Teva Pharmaceutical Industries, an Israeli multinational pharmaceutical company, was hit with a patent infringement lawsuit on April 8 in Delaware District Court. The court action, asserting 12 ...